All Stories

  1. In vitro Characterization of a novel murine model of cancerous progression

    Article • Advances in Cancer Biology - Metastasis, July 2023, Elsevier

    Professor Dennis Paul

  2. Effect of Cell Cycle on Cell Surface Expression of Voltage-Gated Sodium Channels and Na+,K+-ATPase

    Article • Cells, October 2022, MDPI AG

    Professor Dennis Paul

  3. Cancer as a Channelopathy—Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments

    Article • Cancers, September 2022, MDPI AG

    Professor Dennis Paul

  4. The Role of Targeted Osmotic Lysis in the Treatment of Advanced Carcinoma in Companion Animals: A Case Series

    Article • Case Reports in Veterinary Medicine, August 2022, Hindawi Publishing Corporation

    Professor Dennis Paul

  5. Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies

    Article • Biomedicines, April 2022, MDPI AG

    Professor Dennis Paul

  6. Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix

    Article • June 2021, MDPI AG

    Professor Dennis Paul

  7. A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis

    Article • European Journal of Medicinal Chemistry, September 2020, Elsevier

    Professor Dennis Paul

  8. Targeted Osmotic Lysis of Highly Invasive Breast Carcinomas Using Pulsed Magnetic Field Stimulation of Voltage-Gated Sodium Channels and Pharmacological Blockade of Sodium Pumps

    Article • Cancers, May 2020, MDPI AG

    Professor Dennis Paul

  9. Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps

    Article • Oncotarget, February 2018, Impact Journals, LLC

    Professor Dennis Paul

  10. Extended-release hydrocodone patient considerations

    Article • Therapeutics and Clinical Risk Management, October 2015, Dove Medical Press

    Professor Dennis Paul

  11. Oxidation-sensitive nociception involved in endometriosis-associated pain

    Article • Pain, March 2015, Wolters Kluwer Health

    Professor Dennis Paul

  12. Hydrocodone extended-release: Pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy

    Article • Pharmacological Research, January 2015, Elsevier

    Professor Dennis Paul

  13. Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury

    Article • Pain Medicine, October 2014, Oxford University Press (OUP)

    Professor Dennis Paul

  14. Regulation and pharmacological blockade of sodium-potassium ATPase: A novel pathway to neuropathy

    Article • Journal of the Neurological Sciences, May 2014, Elsevier

    Professor Dennis Paul

  15. PDZK1 Is a Novel Factor in Breast Cancer That Is Indirectly Regulated by Estrogen through IGF-1R and Promotes Estrogen-Mediated Growth

    Article • Molecular Medicine, January 2013, Springer Science + Business Media

    Professor Dennis Paul

  16. Measurement of CFA-Induced Hyperalgesia and Morphine-Induced Analgesia in Rats: Dorsal vs Plantar Mechanical Stimulation of the Hindpaw

    Article • Pain Medicine, March 2011, Oxford University Press (OUP)

    Professor Dennis Paul

  17. Experimental Designs for the Study of Receptor–Receptor Interactions

    Article • January 2011, Springer Science + Business Media

    Professor Dennis Paul

  18. Insulin Is Essential for the Recovery from Allodynia Induced by Complete Freund's Adjuvant

    Article • Pain Medicine, September 2010, Oxford University Press (OUP)

    Professor Dennis Paul

  19. Ranolazine Attenuation of CFA-induced Mechanical Hyperalgesia

    Article • Pain Medicine, January 2010, Oxford University Press (OUP)

    Professor Dennis Paul

  20. Ranolazine attenuates behavioral signs of neuropathic pain

    Article • Behavioural Pharmacology, December 2009, Wolters Kluwer Health

    Professor Dennis Paul

  21. Medications of abuse in pain management

    Article • Current Opinion in Anaesthesiology, August 2007, Wolters Kluwer Health

    Professor Dennis Paul

  22. Synthesis and in vivo evaluation of non-hepatotoxic acetaminophen analogs

    Article • Bioorganic & Medicinal Chemistry, March 2007, Elsevier

    Professor Dennis Paul

  23. Classical Models for Drug Receptor Interactions

    Article • January 2007, Elsevier

    Professor Dennis Paul

  24. Drug-Receptor Interactions

    Article • January 2007, Elsevier

    Professor Dennis Paul

  25. Quantitative Parameters of Drug Action

    Article • January 2007, Elsevier

    Professor Dennis Paul

  26. Ibuprofen blocks changes in nav 1.7 and 1.8 sodium channels associated with complete freund's adjuvant–induced inflammation in rat

    Article • Journal of Pain, June 2004, Elsevier

    Professor Dennis Paul

  27. Synthesis and Biological Evaluation at Nicotinic Acetylcholine Receptors ofN-Arylalkyl- andN-Aryl-7-Azabicyclo[2.2.1]heptanes

    Article • Journal of Medicinal Chemistry, July 2002, American Chemical Society (ACS)

    Professor Dennis Paul

  28. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments

    Article • European Journal of Pharmacology, February 2000, Elsevier

    Professor Dennis Paul

  29. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain

    Article • Brain Research, January 2000, Elsevier

    Professor Dennis Paul

  30. Development of inflammatory hypersensitivity and augmentation of sodium channels in rat dorsal root ganglia

    Article • Brain Research, April 1999, Elsevier

    Professor Dennis Paul

  31. The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding

    Article • Life Sciences, October 1997, Elsevier

    Professor Dennis Paul

  32. Analgesic effects of Tyr-W-MIF-1: a mixed μ2-opioid receptor receptor antagonist

    Article • European Journal of Pharmacology, November 1996, Elsevier

    Professor Dennis Paul

  33. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to μ1 and μ2 opiate receptors

    Article • Neuroscience Letters, August 1996, Elsevier

    Professor Dennis Paul

  34. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by α2-adrenoceptors

    Article • European Journal of Pharmacology, March 1996, Elsevier

    Professor Dennis Paul

  35. Effects of κ-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney

    Article • European Journal of Pharmacology Molecular Pharmacology, May 1995, Elsevier

    Professor Dennis Paul

  36. Differential cross-tolerance between analgesia produced by α2-adrenoceptor agonists and receptor subtype selective opioid treatments

    Article • European Journal of Pharmacology, January 1995, Elsevier

    Professor Dennis Paul

  37. Potentiation of intrathecal DAMGO antinociception, but not gastrointestinal transit inhibition, by 5-hydroxytryptamine and norepinephrine uptake blockade

    Article • Life Sciences, December 1994, Elsevier

    Professor Dennis Paul

  38. Analgesic potency of TRIMU-5: A mixed μ2 opioid receptor agonists/μ1 opioid receptor antagonist

    Article • European Journal of Pharmacology, June 1992, Elsevier

    Professor Dennis Paul

  39. Potentiation of opioid analgesia by the antidepressant nefazodone

    Article • European Journal of Pharmacology, February 1992, Elsevier

    Professor Dennis Paul

  40. Evidence of hyperglycemic hyperalgesia by quinpirole

    Article • Pharmacology Biochemistry and Behavior, January 1992, Elsevier

    Professor Dennis Paul

  41. Genetic influences in opioid analgesic sensitivity in mice

    Article • Brain Research, December 1991, Elsevier

    Professor Dennis Paul

  42. Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus

    Article • Brain Research, September 1991, Elsevier

    Professor Dennis Paul

  43. Gender effects and central opioid analgesia

    Article • Pain, April 1991, Wolters Kluwer Health

    Professor Dennis Paul

  44. Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions

    Article • Life Sciences, January 1991, Elsevier

    Professor Dennis Paul

  45. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus

    Article • Brain Research, October 1990, Elsevier

    Professor Dennis Paul

  46. Proglumide selectively potentiates supraspinal μ1 opioid analgesia in mice

    Article • Neuropharmacology, May 1990, Elsevier

    Professor Dennis Paul

  47. The serotonin type-2 receptors that inhibit opioid analgesia are in the brain.

    Article • Psychopharmacology, March 1990, Springer Science + Business Media

    Professor Dennis Paul

  48. Associative factors in tolerance to analgesia produced by electrical stimulation in the brainstem.

    Article • Behavioral Neuroscience, January 1990, American Psychological Association (APA)

    Professor Dennis Paul

  49. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists

    Article • Brain Research, October 1989, Elsevier

    Professor Dennis Paul

  50. Different μ receptor subtypes mediate spinal and supraspinal analgesia in mice

    Article • European Journal of Pharmacology, September 1989, Elsevier

    Professor Dennis Paul

  51. Contingent tolerance and cross-tolerance to anticonvulsant drug effects: Pentobarbital and ethanol

    Article • Psychobiology, June 1989, Springer Science + Business Media

    Professor Dennis Paul

  52. Chronic opioid antagonist treatment increases μ and δ receptor mediated spinal cord opioid analgesia

    Article • Brain Research, April 1989, Elsevier

    Professor Dennis Paul

  53. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model

    Article • Life Sciences, January 1989, Elsevier

    Professor Dennis Paul

  54. Serotonin type-2 receptors that mediate morphine analgesia are in the central nervous system

    Article • Pharmacology Biochemistry and Behavior, November 1988, Elsevier

    Professor Dennis Paul

  55. Erratum to: Observations

    Article • Psychobiology, June 1988, Springer Science + Business Media

    Professor Dennis Paul

  56. Differential blockade by naloxonazine of two μ opiate actions: Analgesia and inhibition of gastrointestinal transit

    Article • European Journal of Pharmacology, May 1988, Elsevier

    Professor Dennis Paul

  57. Observations

    Article • Psychobiology, March 1988, Springer Science + Business Media

    Professor Dennis Paul

  58. Serotonin type-2 receptors mediate opioid analgesia.

    Article • Psychopharmacology, January 1986, Springer Science + Business Media

    Professor Dennis Paul